119 related articles for article (PubMed ID: 27829580)
1. Inhibitory effect of ethinylestradiol on coagulation factors in rats.
Franco-Murillo Y; Jaimez R
Exp Anim; 2017 May; 66(2):107-113. PubMed ID: 27829580
[TBL] [Abstract][Full Text] [Related]
2. Changes on hemostatic parameters induced by 17beta-estradiol, ethinylestradiol, and the 17beta-aminoestrogen pentolame in the male Wistar rat.
García-Manzano A; González-Llaven J; Jaimez R; Franco Y; Estela Avila M; Rubio-Póo C; Lemini C
Steroids; 2002 Dec; 67(13-14):1129-35. PubMed ID: 12441199
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic Effects of Raloxifene in Ovariectomized Rats.
Alva-Chavarría D; Soto-Núñez M; Flores-Soto E; Jaimez R
Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511987
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
[TBL] [Abstract][Full Text] [Related]
6. Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?
Martinuzzo M; Barrera L; Rodriguez M; D'Adamo MA; López MS; Otaso JC
Int J Lab Hematol; 2015 Dec; 37(6):853-60. PubMed ID: 26338156
[TBL] [Abstract][Full Text] [Related]
7. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
Ferreira AC; Montes MB; Franceschini SA; Toloi MR
Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
[TBL] [Abstract][Full Text] [Related]
8. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
9. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
10. 17α-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α.
Cleuren AC; Van der Linden IK; De Visser YP; Wagenaar GT; Reitsma PH; Van Vlijmen BJ
J Thromb Haemost; 2010 Aug; 8(8):1838-46. PubMed ID: 20524981
[TBL] [Abstract][Full Text] [Related]
11. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats.
Lemini C; Jaimez R; Medina-Jiménez M; Ávila ME
Indian J Pharmacol; 2012; 44(6):749-53. PubMed ID: 23248406
[TBL] [Abstract][Full Text] [Related]
13. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
14. EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.
Kuo KH; Khan S; Rand ML; Mian HS; Brnjac E; Sandercock LE; Akula I; Julien JP; Pai EF; Chesney AE
PLoS One; 2016; 11(3):e0149830. PubMed ID: 26934472
[TBL] [Abstract][Full Text] [Related]
15. Interaction between ethanol and contraceptive steroids on clotting activity in the rat.
Lox CD; Heine MW
Contraception; 1983 Apr; 27(4):401-7. PubMed ID: 6851568
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Kebapcilar L; Taner CE; Kebapcilar AG; Alacacioglu A; Sari I
Arch Gynecol Obstet; 2010 Jan; 281(1):35-42. PubMed ID: 19330342
[TBL] [Abstract][Full Text] [Related]
17. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
18. Effect of quinestrol on the coagulation mechanism.
Lenahan JG; Stough A; Bronstein SB
Int J Fertil; 1967; 12(2):271-3. PubMed ID: 5342278
[No Abstract] [Full Text] [Related]
19. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Bonnar J; Daly L; Carroll E
Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
[TBL] [Abstract][Full Text] [Related]
20. Somatotropin and somatostatin effects on vitamin K-dependent plasma coagulation factors.
Negrev N; Nyagolov Y; Stanchewa E
Eur J Pharmacol; 1995 Apr; 277(2-3):145-9. PubMed ID: 7493602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
